Retatrutide vs Mazdutide: Comparing Next-Generation Incretin Agonists in Preclinical Research
A research-focused comparison of Retatrutide vs Mazdutide, contrasting triple- and dual-receptor architecture, hepatic vs systemic endpoints, and current Phase 2/3 evidence.